LIFEMD, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
LIFEMD, INC. (LFMD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $267.89 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2019-04-01.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2019-04-01
- LIFEMD, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2017-12-31 was -$2.03M.
- LIFEMD, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2017-09-30 was $947.76K.
- LIFEMD, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2017-06-30 was -$2.13M.
- LIFEMD, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2017-03-31 was $3.26M.
- LIFEMD, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2018 was $267.89K, a 396.10% increase from fiscal 2017.
- LIFEMD, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2017 was $54.00K, a 0.00% change from fiscal 2016.
- LIFEMD, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2016 was $54.00K.
- LIFEMD, INC. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2013 was $50.00K, a 53.85% increase from fiscal 2012.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | $267.89K 10-K · filed 2019-04-01 | ||||
| 2017-12-31 | -$2.03M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | -$1.08M derived: sum of 2 quarters · filed 2019-04-01 | -$3.21M derived: sum of 3 quarters · filed 2019-04-01 | $54.00K 10-K · filed 2019-04-01 | $267.89K 10-K · filed 2018-04-02 |
| 2017-09-30 | $947.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$1.18M derived: sum of 2 quarters · filed 2017-11-14 | $2.08M 10-Q · filed 2017-11-14 | ||
| 2017-06-30 | -$2.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $1.13M 10-Q · filed 2017-08-14 | |||
| 2017-03-31 | $3.26M 10-Q · filed 2017-07-07 | ||||
| 2016-12-31 | $54.00K 10-K · filed 2018-04-02 | ||||
| 2013-12-31 | -$50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | -$50.00K derived: sum of 2 quarters · filed 2015-03-30 | $50.00K 10-K · filed 2015-03-30 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $100.00K 10-Q · filed 2013-11-14 | |||
| 2013-06-30 | $100.00K 10-Q · filed 2013-08-14 | ||||
| 2012-12-31 | $32.50K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |